Apple stores to stock chrome-plated glucose monitor from One Drop

The system features a predictive algorithm that forecasts glucose levels out to eight hours for Apple iOS users with type 2 diabetes, including those on oral medications or a basal insulin regimen. (Image: One Drop)

Apple, continuing its long march into healthcare, has begunstarted selling a fashionable, chrome-plated blood sugar monitor alongside its iPhones and Apple Watches in some of its U.S. retail stores. 

The glucose monitoring system, including a lancet, tester and strips, is developed by One Drop. It wirelessly syncs diabetes data with Apple’s devices and health apps, and had previously been available on the tech giant’s online storefront. 

Purchasers also receive one year of coaching via One Drop’s program, which includes digital tools for tracking medication, food intake and physical activity, and also offers test-strip subscription options. Apple had previously stocked Sanofi’s plug-in glucose meter for the iPhone, cleared in 2012. 

Webinar

De-risking the Development of Biotherapeutics Using Early Stage In Vitro Expression and Genetic Characterisation Tools

There is a high attrition rate during the development of biotherapeutics impacting the high cost of development. Early identification of the preferred expression host for manufacturing, along with lead candidate screening and material supply can help to reduce both attrition rates and cost.

"The healthcare industry is deeply invested in resisting progress, but consumerized, data-driven, digital health is becoming a reality," One Drop founder and CEO Jeff Dachis said in a statement

RELATED: Report: Study shows promise of Apple’s Health Records service

While not exactly a thrown sledgehammer, the system does feature a predictive algorithm that launched earlier this month, which forecasts glucose levels out to eight hours for Apple iOS users with type 2 diabetes, including those on oral medications or a basal insulin regimen.

RELATED: MannKind, One Drop to study Afrezza-app combo in Type 2 diabetes

One Drop says its machine learning-based predictions are powered by over 2.2 billion data points, collected from more than 1.2 million users. Alongside each forecast, users also receive advice on relevant behaviors for maintaining time-in-range.

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

The supermarket chain received an emergency authorization for its own home collection kit for COVID-19 testing, which includes a telehealth consult.

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.